Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
|
|
Anzu Special Acquisition Corp I
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
8-K
| Quarterly results |
| 10/05/2023 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failur...|
Docs:
|
"Second Amended and Restated Certificate of Incorporation of the Company",
"Amended and Restated Bylaws of the Company",
"Certificate of Designation of Series A Preferred Stock of the Company",
"Amendment to Letter Agreement, by and among Anzu, the Sponsor and Anzu’s officers and directors",
"Amended and Restated Registration Rights Agreement, by and among Anzu Special Acquisition Corp I, Anzu SPAC GP I LLC and certain stockholders",
"Amendment to Letter Agreement, by and among Anzu, the Sponsor and Anzu’s officers and directors",
"Envoy Medical, Inc. Equity Incentive Plan",
"Envoy Medical, Inc. Employee Stock Purchase Plan",
"Amendment No. 2 to Forward Purchase Agreement",
"List of subsidiaries" |
|
| 09/27/2023 |
8-K
| Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits &...|
Docs:
|
"Anzu Special Acquisition Corp I Stockholders Approve Business Combination with Envoy Medical Corporation Tampa, Florida — September 27, 2023 — Anzu Special Acquisition Corp I , announced today that its stockholders voted to approve the Business Combination Agreement with Envoy Medical Corporation , and the transactions contemplated thereby at the Company’ s special meeting of stockholders held on September 27, 2023 . Pursuant to the Business Combination Agreement, Merger Sub will merge with and into Envoy, with Envoy surviving the merger as a wholly owned subsidiary of the Company . Following the closing of the Merger , the Company will be renamed “Envoy Medical, Inc.”, which is referred to herein as “New Envoy.” Over 99% of the votes cast at the Special Meeting were cast in favor of the a..." |
|
| 04/18/2023 |
8-K
| Quarterly results |
| 04/03/2023 |
8-K
| Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review  ... |
| 03/02/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
| 02/24/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data|
Docs:
|
"EXTENSION SUPPORT AGREEMENT This EXTENSION SUPPORT AGREEMENT , dated as of [●], 2023 is made by and between Anzu Special Acquisition Corp I, a Delaware corporation , Anzu SPAC GP I LLC, a Delaware limited liability company , and the undersigned holders . WHEREAS, the Sponsor currently holds 10,500,000 shares of Class B common stock, par value $0.0001 per share, of Anzu , which Sponsor Shares shall convert automatically into shares of Class A common stock, par value $0.0001 per share, of Anzu , at the time of the Initial Business Combination ; WHEREAS, Anzu has entered into a letter of intent regarding an Initial Business Combination with Envoy Medical Corporation , a U.S.-based medical device company that has developed and is in early clinical testing of an implanted device that has ..." |
|
| 02/22/2023 |
8-K
| Investor presentation |
| 02/09/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Anzu Special Acquisition Corp I Announces Adjournment of Special Meeting of Stockholders Tampa, Florida — February 9, 2023 — Anzu Special Acquisition Corp I , announced today that it convened and then adjourned, without conducting any other business, the Company’ s special meeting of stockholders held on February 9, 2023. The Special Meeting has been adjourned until 9:30 a.m., Eastern time, on February 21, 2023 . The Adjourned Special Meeting will be held virtually via live webcast at https://web.lumiagm.com/274911563. The record date remains the close of business, Eastern Time, on January 17, 2023. At the Adjourned Special Meeting, stockholders will be asked to vote on a proposal to amend the Company’ s amended and restated certificate of incorporation to extend the date by which the Comp..." |
|
| 02/06/2023 |
8-K
| Quarterly results |
| 10/04/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/04/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o... |
| 01/26/2022 |
8-K/A
| Financial Statements and Exhibits Interactive Data |
| 12/07/2021 |
8-K
| Quarterly results |
| 12/03/2021 |
8-K
| Quarterly results |
| 04/21/2021 |
8-K
| Quarterly results |
| 04/20/2021 |
8-K
| Quarterly results |
| 03/10/2021 |
8-K
| Quarterly results |
| 03/04/2021 |
8-K
| Quarterly results |
|
|